Skip to main content
GENEDRIVE PLC logo

GENEDRIVE PLC — Investor Relations & Filings

Ticker · GDR ISIN · GB00B1VKB244 LEI · 213800ZYODIRZ87Y4K14 IL Manufacturing
Open in API
Filings indexed 605 across all filing types
Latest filing 2025-10-31 Capital/Financing Update
Country GB United Kingdom
Listing IL GDR

About GENEDRIVE PLC

https://genedriveplc.com/

Genedrive PLC is a molecular diagnostics company specializing in the development and commercialization of a rapid, point-of-care pharmacogenetic testing platform. The company's core technology, the Genedrive® System, is designed for the swift diagnosis of genetic variants to enable personalized medicine in critical care settings. Its key products include the Genedrive® MT-RNR1 ID Kit, used to prevent antibiotic-induced hearing loss in infants, and the Genedrive® CYP2C19 ID Kit, which helps optimize antiplatelet therapy for stroke patients. The platform empowers clinicians to make safer and more effective treatment decisions by providing crucial genetic information at the point of need, thereby improving patient outcomes.

Recent filings

Filing Released Lang Actions
Potential Shareholder Loan
Capital/Financing Update Classification · 1% confidence The document is an RNS announcement from Genedrive PLC regarding a potential shareholder loan from a 16% shareholder. It details ongoing discussions about financing options and a potential cash injection. This falls under the category of company fundraising and financing activities, which is defined by the CAP (Capital/Financing Update) code.
2025-10-31 English
Holding(s) in Company
Major Shareholding Notification Classification · 1% confidence The document is a 'TR-1: Standard form for notification of major holdings' for Genedrive PLC. This form is used to report when a shareholder's interest in a company crosses a specific threshold, which is a classic 'Major Shareholding Notification'. The document explicitly lists the identity of the issuer, the person subject to the notification (Mr. David Nugent), and the percentage of voting rights held (16.035%). This fits the definition of a Major Shareholding Notification (MRQ).
2025-10-29 English
MOU with Kingdom of Saudi Arabia for MT-RNR1 ID
Regulatory Filings Classification · 1% confidence The document is a press release distributed via the London Stock Exchange's RNS (Regulatory News Service). It announces a Memorandum of Understanding (MOU) between Genedrive PLC and the Saudi Ministry of Health regarding a pilot program for a medical testing kit. As this is a general corporate announcement regarding business operations and partnerships that does not fit into specific categories like M&A, dividends, or financial reports, it falls under the fallback category of Regulatory Filings (RNS).
2025-10-28 English
Application for Listing & Total Voting Rights
Share Issue/Capital Change Classification · 1% confidence The document is an RNS (Regulatory News Service) announcement from Genedrive PLC regarding the exercise of warrants and the subsequent application for the admission of new ordinary shares to trading on AIM. This constitutes a change in the company's share capital structure. According to the provided definitions, announcements regarding new share issues or capital changes fall under the 'Share Issue/Capital Change' (SHA) category.
2025-10-24 English
Result of General Meeting
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is an official announcement from Genedrive PLC regarding the 'Result of General Meeting'. It provides a detailed breakdown of poll voting results for specific resolutions, which directly aligns with the definition of a 'Declaration of Voting Results & Voting Rights Announcements' (DVA). While it mentions the failure of a financing proposal, the primary purpose and structure of the document are to report the outcome of the shareholder vote.
2025-10-15 English
Holding(s) in Company
Major Shareholding Notification Classification · 1% confidence The document is a 'TR-1: Standard form for notification of major holdings' for Genedrive PLC. This form is used to report when a shareholder's interest in a company crosses a specific threshold (in this case, 15.1%). This falls under the category of Major Shareholding Notification.
2025-10-10 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.